PIERINI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 1.235
EU - Europa 880
AS - Asia 194
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 2.312
Nazione #
US - Stati Uniti d'America 1.234
IT - Italia 304
IE - Irlanda 292
HK - Hong Kong 137
SE - Svezia 47
UA - Ucraina 41
CN - Cina 34
FI - Finlandia 32
RU - Federazione Russa 32
AT - Austria 25
FR - Francia 24
DE - Germania 14
GB - Regno Unito 14
TR - Turchia 14
CH - Svizzera 13
BE - Belgio 12
RO - Romania 8
PL - Polonia 6
NL - Olanda 5
CZ - Repubblica Ceca 4
LB - Libano 3
GR - Grecia 2
HR - Croazia 2
SG - Singapore 2
UZ - Uzbekistan 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
CA - Canada 1
DK - Danimarca 1
IM - Isola di Man 1
IN - India 1
SC - Seychelles 1
TW - Taiwan 1
Totale 2.312
Città #
Dublin 292
Chandler 253
San Mateo 240
Hong Kong 135
Perugia 119
Altamura 75
Andover 60
Medford 59
Princeton 58
Lawrence 55
Wilmington 53
Ann Arbor 38
Beijing 29
Vienna 24
Des Moines 21
Redmond 20
San Paolo di Civitate 20
Los Angeles 16
Norwalk 15
Jacksonville 14
New York 14
Dearborn 13
Falls Church 13
Brussels 11
Rome 11
Saint Petersburg 11
Houston 8
Redwood City 8
West Jordan 8
Bucharest 7
Helsinki 7
Izmir 7
Foligno 6
Ancona 5
Florence 5
Kocaeli 5
Milan 5
Ashburn 4
Gubbio 4
Lappeenranta 4
Moscow 4
Aurora 3
Den Haag 3
Padova 3
Terni 3
Vigodarzere 3
Woodbridge 3
Amsterdam 2
Arezzo 2
Boardman 2
Bologna 2
Cambridge 2
Castelfranco Emilia 2
Chicago 2
Guangzhou 2
Lausanne 2
Mirano 2
Seattle 2
Singapore 2
Spello 2
Venice 2
Zagreb 2
Apo 1
Athens 1
Baotou 1
Battipaglia 1
Belgioioso 1
Boston 1
Collazzone 1
Copenhagen 1
Douglas 1
Fairfield 1
Falkenstein 1
Formigine 1
Grosseto 1
Göteborg 1
Istanbul 1
London 1
Marcallo con Casone 1
Mogliano 1
Odesa 1
Ottawa 1
Phoenix 1
Pouso Alegre 1
Prague 1
Radcliffe 1
San Benedetto Del Tronto 1
Sanliurfa 1
Shenzhen 1
Sigillo 1
Taipei 1
Tappahannock 1
Timisoara 1
Xian 1
Totale 1.836
Nome #
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 72
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 66
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 64
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 61
T regulatory cell separation for clinical application. 60
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 59
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 58
TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation 55
The effect of TNF-α on regulatory T cell function in graft-versus-host disease 53
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 53
TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 50
NK cell reconstitution is improved during allogeneic hematopoietic stem cell transplantation by infusion of NK cell-committed progenitor cells (HEM5P. 233) 48
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 48
CMV management with specific immunoglobulins: A multicentric retrospective analysis on 92 allotransplanted patients 48
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. 46
"Designed" grafts for HLA-haploidentical stem cell transplantation. 46
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 46
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease 46
New mechanism of lymphoma-induced bone marrow aplasia 45
T cells expressing chimeric antigen receptor promote immune tolerance 44
CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation 44
Foxp3+regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesis 43
Impact of Donor T Cells on NK Cell Development after Allogeneic Hematopoietic Cell Transplantation 41
Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: A global health initiative by the international consortium of total marrow irradiation 41
CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts 38
FISH analysis reveals frequent co-occurrence of 4q24/TET2 and 5q and/or 7q deletions. 37
The Evolution of T Cell Depleted Haploidentical Transplantation 37
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 36
Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation 35
Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease 35
DR3 signaling modulates the function of Foxp3+regulatory T cells and the severity of acute graft-versus-host disease 35
CD41 invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD41CD251FoxP31 regulatory T cells 35
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 35
Engraftment of Embryonic Stem Cells and Differentiated Progeny by Host Conditioning with Total Lymphoid Irradiation and Regulatory T Cells 34
Control of alloreactivity using transient expression of a monoclonal antibody directed chimeric antigen receptor in conventional and regulatory T cells 34
null 34
Chronic stimulation results in NK cell function impairment mediated by NKG2D 33
Mutational analisys of JAK2 VAL617PHE in a new series of chronic myelomonocytic leukemia and related atypical myeloproliferative disorders 32
Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease 32
The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Facilitate Conventional T Cell and Treg Control of GvHD and Tissue Tolerance in Murine Models 30
Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway 30
CD4+FoxP3+Regulatory T Cells Regulate B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts 29
NPM1 haploinsufficiency in MDS/AML with del(5q)/monosomy 5 27
TIM-1 Blockade of the Donor Graft Provides Protection Against Lethal Gvhd 27
Freeze and thaw of CD4+CD25+Foxp3+ regulatory T cells results in loss of CD62L expression and a reduced capacity to protect against graft-versus-host disease 27
Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia 27
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 26
TIM-1 blockade of the donor graft provides protection against lethal GVHD 25
Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement 24
TNF-α priming enhances CD4+FoxP3+regulatory T-cell suppressive function in murine GVHD prevention and treatment 24
NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment 24
Mast cells suppress murine GVHD in a mechanism independent of CD4+ CD25+ regulatory T cells 23
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 22
TNF-Alpha Priming Enhances CD4(+) FoxP3(+) Regulatory T Cell Suppressive Function in GvHD Prevention and Treatment 22
Regulatory T Cell Immunotherapy in Immune-Mediated Diseases 22
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 21
Host CD4+CD25+FoxP3+Regulatory T Cells Facilitate Donor Engraftment Without Impacting Graft Versus Host Disease Onset After Major-Mismatched Hematopoietic Stem Cell Transplantation 21
The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Guide T Cell and Treg Homing for GvHD Control and Tissue Tolerance in Murine Models 21
Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells 21
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis 19
TNF-Alpha Priming Enhances CD4+FoxP3+ Regulatory T Cell Suppressive Function in GVHD Prevention and Treatment 19
Feasibility of a Novel Sparse Orthogonal Collimator–Based Preclinical Total Marrow Irradiation for Enhanced Dosimetric Conformality 18
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 18
NPM1 monoallelic deletion in a subgroup of MDS/AML with del(5q) or monosomy 5 and complex karyotype 17
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 16
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 16
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 12
null 12
How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia 11
Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice 11
Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation 11
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation 11
HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia 10
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 9
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax 9
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 7
Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation 7
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation 7
First Multimodal, Three-Dimensional, Image-Guided Total Marrow Irradiation Model for Preclinical Bone Marrow Transplantation Studies 6
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 6
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion 4
TREG/TCON immunotherapy promotes HSC-derived B lymphopoiesis and boosts B cell immunity after haploidentical transplantation. 1
Totale 2.509
Categoria #
all - tutte 11.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201919 0 0 0 0 0 0 0 0 0 4 13 2
2019/2020130 8 5 7 4 11 8 9 5 18 46 5 4
2020/2021194 2 7 4 7 115 6 7 2 15 8 17 4
2021/2022654 9 199 1 15 29 7 10 175 11 25 101 72
2022/2023960 63 212 12 53 62 91 5 39 335 23 48 17
2023/2024317 15 60 17 14 2 14 120 8 41 26 0 0
Totale 2.509